APA (7th ed.) Citation

SC, M., J, T., M, S., A, C., A, M., S, A., . . . F, A. (2021). Commission on Cancer CP3R Compliance Rates for Treatment of Patients With Triple Negative and HER2+ Breast Cancer: A National Cancer Database Analysis. The American surgeon, 87(10), 1539. https://doi.org/10.1177/00031348211051674

Chicago Style (17th ed.) Citation

SC, Mohan, Tseng J, Srour M, Chung A, Marumoto A, Angarita S, Giuliano AE, and Amersi F. "Commission on Cancer CP3R Compliance Rates for Treatment of Patients With Triple Negative and HER2+ Breast Cancer: A National Cancer Database Analysis." The American Surgeon 87, no. 10 (2021): 1539. https://doi.org/10.1177/00031348211051674.

MLA (9th ed.) Citation

SC, Mohan, et al. "Commission on Cancer CP3R Compliance Rates for Treatment of Patients With Triple Negative and HER2+ Breast Cancer: A National Cancer Database Analysis." The American Surgeon, vol. 87, no. 10, 2021, p. 1539, https://doi.org/10.1177/00031348211051674.